Mista
SENIOR MEMBER
- Joined
- Jun 9, 2016
- Messages
- 4,567
- Reaction score
- 10
- Country
- Location
Sinovac is not sinopharm mate, majority Chinese vaccine is Sinopharm which has higher efficacy. The problem is 2 years of bliss cultivated complacency in Shanghai, their lockdown criteria and mass testing criteria was really low compared to other cities. SINOVAC was designed for the first variant and had high efficacy against death and severe illness, 2 dose Sinovac is useless against omicron.
However, 3 dose Sinovac has almost same efficacy as Pfizer 3 dose as per HK data. You can go to sinodefence forum for that debate. Next, Chinese daat is rather accurate for infected and death, they take it really seriously, the reason why we can't open up so soon was because if it spreads the strain on the medical system. Would be tremendous.
Cehck CDC data not worldometer, its not accurate.
For the US situation, I don't think it's taht simple, there are no longer mass testing and only doing selective testing based on symptoms. The figure is even higher. Death is 3x of Chinese death, that's a fact. If you were to accumulate the death for 35 days compared to 500+ deaths in Shnaghai for 35 days, then you can see the gap is even bigger.
Shnaghai has almost 900k infected including asymptomatic, 600/900000 death rate is 0.06% death rate. The guys math is wrong.
No one doubts that the US is having more Covid deaths than Shanghai, but it's more like they are currently having 300+ deaths per day and not 1900 you claimed which is a huge difference.
COVID Data Tracker
CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.
covid.cdc.gov